Abstract:In neurosurgery, the precise diagnosis and treatment of tumor diseases are challenging to realize. Current clinical diagnoses lack fast and accurate intraoperative information. Therefore, the development of new methods and techniques to assist neurosurgeons intraoperatively is necessary. Optical diagnosis is a promising method to provide accurate information about biological tissues in a short time. Therefore, in this study, we proposed a dual-modality optical diagnostic method through point-to-face registration fusion in the optical system. We incorporated quantitative autofluorescence spectroscopy and optical coherence tomography (OCT) and evaluated our methods in an animal model. Methods: A mouse model consisting of 16 nude mice was built by injecting the mouse brains with human glioma cells. Preoperative bioluminescence imaging was used to evaluate the growth states of tumors and locate the tumor sites. Quantitative autofluorescence spectroscopy, which provided local biochemical information with single-point detection, and OCT, which provided relatively global structural information with en face mapping scanning, were combined using the point-to-face registration fusion method to provide precise diagnostic information for identifying the brain tumors. Postoperative pathology was performed to evaluate the sensitivity and specificity of optical diagnosis. Results: Ex vivo quantitative autofluorescence spectroscopy and OCT imaging were first performed in eight mice to acquire the optimal measuring parameters for tumor staging and identification. We then performed in vivo quantitative autofluorescence spectroscopy and OCT imaging. The results showed that tumor staging could be realized through quantitative autofluorescence spectroscopy, and fusion images could be used to precisely identify tumors. The autofluorescence spectral map, OCT en face map, and fused diagnostic map had average sensitivities of 91.7%, 86.1%, and 95.9% and specificities of 93.2%, 96.0%, and 88.7%, respectively, for tumor identification. Conclusion: The dual-modality optical point-to-face registration fusion method and system we proposed could provide both biochemical information and structural information. The in vivo experimental results validated that the sensitivity (95.9%) of the fused map was higher than that of either single diagnostic modality (86.1% or 91.7%). Tumor staging was realized through quantitative autofluorescence spectroscopy. The proposed method will be applicable to future intelligent theranostic systems and improve many clinical neurosurgeries.

Pathological identification of brain tumors based on the characteristics of molecular fragments generated by laser ablation combined with a spiking neural network

Glioma Identification Based on Digital Multimodal Spectra Integrated With Deep Learning Feature Fusion Using a Miniature Raman Spectrometer

Distinguishing brain tumors by Label-free confocal micro-Raman spectroscopy

Machine Learning-Assisted Classification of Paraffin-Embedded Brain Tumors with Raman Spectroscopy

Identification of tumor tissue in thin pathological samples via femtosecond laser-induced breakdown spectroscopy and machine learning

Accurate and rapid molecular subgrouping of high-grade glioma via deep learning-assisted label-free fiber-optic Raman spectroscopy

Epi-Detected Hyperspectral Stimulated Raman Scattering Microscopy for Label-Free Molecular Subtyping of Glioblastomas

Brain tumor classification utilizing pixel distribution and spatial dependencies higher-order statistical measurements through explainable ML models

Dual-modality Optical Diagnosis for Precise in Vivo Identification of Tumors in Neurosurgery

Hyperspectral imaging for tissue classification in glioblastoma tumor patients: a deep spectral-spatial approach

Nimg-18. Rapid Intraoperative Differentiation Of Primary Cns Lymphoma From Common Cns Tumors Using Stimulated Raman Histology And Deep Learning

A Distinction of Gliomas at Cellular and Tissue Level by Surface-Enhanced Raman Scattering Spectroscopy

Spatio-spectral classification of hyperspectral images for brain cancer detection during surgical operations

Multilayer Stacked Probabilistic Belief Network-Based Brain Tumor Segmentation and Classification

Streamlined Intraoperative Brain Tumor Classification and Molecular Subtyping in Stereotactic Biopsies Using Stimulated Raman Histology and Deep Learning

Fast Real-Time Brain Tumor Detection Based on Stimulated Raman Histology and Self-Supervised Deep Learning Model

Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy

Artificial intelligence neuropathologist for glioma classification using deep learning on hematoxylin and eosin stained slide images and molecular markers

Advancing multi-categorization and segmentation in brain tumors using novel efficient deep learning approaches

Detection and isolation of brain tumors in cancer patients using neural network techniques in MRI images

Active deep neural network features selection for segmentation and recognition of brain tumors using MRI images